Exact Mass: 287.2613

Exact Mass Matches: 287.2613

Found 68 metabolites which its exact mass value is equals to given mass value 287.2613, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Procyclidine

1-cyclohexyl-1-phenyl-3-(pyrrolidin-1-yl)propan-1-ol

C19H29NO (287.2249)


Procyclidine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. [PubChem]The mechanism of action is unknown. It is thought that Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia. Many of its effects are due to its pharmacologic similarities with atropine. Procyclidine exerts an antispasmodic effect on smooth muscle, and may produce mydriasis and reduction in salivation. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Dodine

doguadine

C15H33N3O2 (287.2573)


   

Lauroyl diethanolamide

N,N-Bis(2-hydroxyethyl)dodecanamide, 9ci. N,N-bis(2-hydroxyethyl)lauramide

C16H33NO3 (287.246)


Lauroyl diethanolamide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .

   

1,18-Diamino-5,9,14-triazaoctadecane

(4-aminobutyl)[4-({3-[(4-aminobutyl)amino]propyl}amino)butyl]amine

C15H37N5 (287.3049)


1,18-Diamino-5,9,14-triazaoctadecane is found in pulses. 1,18-Diamino-5,9,14-triazaoctadecane is isolated from Canavalia gladiata (sword bean). Isolated from Canavalia gladiata (sword bean). 1,18-Diamino-5,9,14-triazaoctadecane is found in pulses.

   

Cycrimine

1-cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol

C19H29NO (287.2249)


Cycrimine is only found in individuals that have used or taken this drug. It is a drug used to reduce levels of acetylcholine to return a balance with dopamine in the treatment and management of Parkinsons disease. Cycrimine binds the muscarinic acetylcholine receptor M1, effectively inhibiting acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of Parkinsons disease. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent Cycrimine is an orally active muscarinic cholinergic receptor (mAChR) M1 antagonist, reduces the acetylcholine levels in parkinson model. Cycrimine shows antispasmodic activity, can be used in studies of behavioral and mental disorder[1][2][3][4].

   

1-methyl-2-(9-phenylnonyl)pyrrolidine

1-methyl-2-(9-phenylnonyl)pyrrolidine

C20H33N (287.2613)


   
   

Solaurethin|Solaurethine

Solaurethin|Solaurethine

C15H33N3O2 (287.2573)


   

Gephyrotoxin

Gephyrotoxin

C19H29NO (287.2249)


   

C17-Sphinganine

C17-Sphinganine

C17H37NO2 (287.2824)


   

Lauryl diethanolamide

N,N-Bis(2-hydroxyethyl)dodecanamide

C16H33NO3 (287.246)


CONFIDENCE standard compound; INTERNAL_ID 2846 CONFIDENCE standard compound; INTERNAL_ID 8767

   

Lauric Acid Diethanolamide

N,N-Bis(2-hydroxyethyl)dodecanamide

C16H33NO3 (287.246)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); May be an alkyl homologue; Digitised from figure: approximate intensities

   

Sphinganine (C17 base)

Sphinganine (C17 base)

C17H37NO2 (287.2824)


   

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

(2R,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2R,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

2-((1S,3aS,6S)-6-((E)-pent-2-en-4-yn-1-yl)dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethan-1-ol

2-((1S,3aS,6S)-6-((E)-pent-2-en-4-yn-1-yl)dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethan-1-ol

C19H29NO (287.2249)


   

C17 Sphinganine

heptadecasphinganine

C17H37NO2 (287.2824)


   

Prosopinine

6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-ol

C16H33NO3 (287.246)


A piperidine alkaloid that is a hydroxypiperidine with a hydroxy group at position C-3, a hydroxymethyl group at C-2, and an 8-hydroxydecyl group at C-6.

   

cycrimine

1-cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol

C19H29NO (287.2249)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent Cycrimine is an orally active muscarinic cholinergic receptor (mAChR) M1 antagonist, reduces the acetylcholine levels in parkinson model. Cycrimine shows antispasmodic activity, can be used in studies of behavioral and mental disorder[1][2][3][4].

   

Clindrol

N,N-Bis(2-hydroxyethyl)dodecanamide, 9ci. N,N-bis(2-hydroxyethyl)lauramide

C16H33NO3 (287.246)


   

N'-(4-Aminobutyl)canavalmine

(4-aminobutyl)[3-({4-[(4-aminobutyl)amino]butyl}amino)propyl]amine

C15H37N5 (287.3049)


   

Stearic acid(d3)

Octadecanoic acid(d3)

C18H33D3O2 (287.2903)


   

Oleic acid (d5)

9Z-octadecenoic acid (d5)

C18H29D5O2 (287.2873)


   

Lauroyl diethanolamide

N,N-Bis(2-hydroxyethyl)dodecanamide

C16H33NO3 (287.246)


   

SPB 17:0;O2

15-Methylhexadecasphinganine

C17H37NO2 (287.2824)


   

2-dodecoxybenzonitrile

2-dodecoxybenzonitrile

C19H29NO (287.2249)


   

lauric acid, compound with morpholine (1:1)

lauric acid, compound with morpholine (1:1)

C16H33NO3 (287.246)


   

octadecanoic-18,18,18-d3 acid

octadecanoic-18,18,18-d3 acid

C18H33D3O2 (287.2903)


   

Dodecylguanidine

Dodecylguanidine

C15H33N3O2 (287.2573)


   

tetrabutylazanium,formate

tetrabutylazanium,formate

C17H37NO2 (287.2824)


   

N-Cyclohexyl-4-[(piperidin-1-yl)methyl]benzene-1,2-diamine

N-Cyclohexyl-4-[(piperidin-1-yl)methyl]benzene-1,2-diamine

C18H29N3 (287.2361)


   

Lithium triisopropyl 2-(6-methylpyridyl)borate

Lithium triisopropyl 2-(6-methylpyridyl)borate

C15H27BLiNO3 (287.2244)


   

Lithium triisopropyl 2-(5-methylpyridyl)borate

Lithium triisopropyl 2-(5-methylpyridyl)borate

C15H27BLiNO3 (287.2244)


   

N-[2-(2-Hydroxyethoxy)ethyl]dodecanamide

N-[2-(2-Hydroxyethoxy)ethyl]dodecanamide

C16H33NO3 (287.246)


   

alpha-Pyrrolidinononanophenone

alpha-Pyrrolidinononanophenone

C19H29NO (287.2249)


   

(2S,3R)-2-aminoheptadecane-1,3-diol

(2S,3R)-2-aminoheptadecane-1,3-diol

C17H37NO2 (287.2824)


   

(R)-Cycrimine

(R)-Cycrimine

C19H29NO (287.2249)


   

10,16-Dihydroxyhexadecanoate

10,16-Dihydroxyhexadecanoate

C16H31O4- (287.2222)


   

9,16-Dihydroxyhexadecanoate

9,16-Dihydroxyhexadecanoate

C16H31O4- (287.2222)


   

(S)-Cycrimine

(S)-Cycrimine

C19H29NO (287.2249)


   

3,16-Dihydroxypalmitate

3,16-Dihydroxypalmitate

C16H31O4- (287.2222)


A hydroxy fatty acid anion that is the conjugate base of 3,16-dihydroxypalmitic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.

   

(2R)-2-hydroperoxyhexadecanoate

(2R)-2-hydroperoxyhexadecanoate

C16H31O4- (287.2222)


   

9,14-Dihydroxyhexadecanoate

9,14-Dihydroxyhexadecanoate

C16H31O4- (287.2222)


   

9,15-Dihydroxyhexadecanoate

9,15-Dihydroxyhexadecanoate

C16H31O4- (287.2222)


   

9,13-Dihydroxyhexadecanoate

9,13-Dihydroxyhexadecanoate

C16H31O4- (287.2222)


   

N-(1,3-dihydroxytetradecan-2-yl)acetamide

N-(1,3-dihydroxytetradecan-2-yl)acetamide

C16H33NO3 (287.246)


   

1-(N,N-Dimethylamino)-3,7,11-trimethyl-2,3-dodecanediol

1-(N,N-Dimethylamino)-3,7,11-trimethyl-2,3-dodecanediol

C17H37NO2 (287.2824)


   

N-(1,3-dihydroxynonan-2-yl)heptanamide

N-(1,3-dihydroxynonan-2-yl)heptanamide

C16H33NO3 (287.246)


   

N-(1,3-dihydroxyoctan-2-yl)octanamide

N-(1,3-dihydroxyoctan-2-yl)octanamide

C16H33NO3 (287.246)


   

N-(1,3-dihydroxydecan-2-yl)hexanamide

N-(1,3-dihydroxydecan-2-yl)hexanamide

C16H33NO3 (287.246)


   

N-(1,3-dihydroxyundecan-2-yl)pentanamide

N-(1,3-dihydroxyundecan-2-yl)pentanamide

C16H33NO3 (287.246)


   

N-(1,3-dihydroxytridecan-2-yl)propanamide

N-(1,3-dihydroxytridecan-2-yl)propanamide

C16H33NO3 (287.246)


   

N-(1,3-dihydroxydodecan-2-yl)butanamide

N-(1,3-dihydroxydodecan-2-yl)butanamide

C16H33NO3 (287.246)


   

1,1,3,3-Tetra-isopropyl-1,2,3-trimethyldisilazane

1,1,3,3-Tetra-isopropyl-1,2,3-trimethyldisilazane

C15H37NSi2 (287.2464)


   

procyclidine

1-Pyrrolidinepropanol, a-cyclohexyl-a-phenyl-

C19H29NO (287.2249)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Lauric Acid Diethanolamide

N,N-Bis(2-hydroxyethyl)dodecanamide

C16H33NO3 (287.246)


   

1,18-Diamino-5,9,14-triazaoctadecane

1,18-Diamino-5,9,14-triazaoctadecane

C15H37N5 (287.3049)


   

15-Methylhexadecasphinganine

15-Methylhexadecasphinganine

C17H37NO2 (287.2824)


   

Sphingosine (d17:0)

SPH(d17:0)

C17H37NO2 (287.2824)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

(2s,6r,7s,8s)-7-[(1e)-buta-1,3-dien-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1e)-buta-1,3-dien-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

aminobutyl canavalmine

NA

C15H37N5 (287.3049)


{"Ingredient_id": "HBIN015857","Ingredient_name": "aminobutyl canavalmine","Alias": "NA","Ingredient_formula": "C15H37N5","Ingredient_Smile": "C(CCNCCCCNCCCNCCCCN)CN","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14261","TCMID_id": "1045","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r)-1-methyl-2-(9-phenylnonyl)pyrrolidine

(2r)-1-methyl-2-(9-phenylnonyl)pyrrolidine

C20H33N (287.2613)


   

(2s,6r,7s,8s)-7-(buta-1,3-dien-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-(buta-1,3-dien-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

(2s,6r,7s,8s)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2e)-penta-2,4-dien-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2e)-penta-2,4-dien-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

(2s,6r,7s,8s)-7-(buta-1,3-dien-1-yl)-2-(penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-(buta-1,3-dien-1-yl)-2-(penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H29NO (287.2249)


   

(2e,4e,8z,11z)-1-(piperidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

(2e,4e,8z,11z)-1-(piperidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

C19H29NO (287.2249)